NSE ScannerHospitals & Diagnostics · Hospital/Nursing Management · NSE: NH · data 2026-10-30
Narayana Hrudayalaya Ltd.
In plain words
Price: 17.8% below its 52-week high of ₹2,093.3.
Delivery: 53.6% of traded shares were kept for delivery over the last 10 sessions, against 57.5% over the last 60.
Latest results: a net profit of ₹301 cr for the quarter ended Sept 2026 (+16.5% on the same quarter a year earlier).
A description of the data, not a recommendation.
Key figures
Growth
| Revenue (last 12 months) | ₹9,072 cr |
| Net profit (last 12 months) | ₹816 cr |
| Sales growth, 3 years (yearly) | 20.4% |
| Profit growth, 3 years (yearly) | 9.9% |
Latest results in brief (Q2 FY27)
NH Q2 FY27 results (consolidated figures, as filed on NSE).
Revenue was ₹2,843.99 crore, up 73% YoY and up 6% QoQ.
Net profit was ₹301.03 crore, up 16.5% YoY and up 45.3% QoQ.
Operating margin was 19.5% (24.5% a year ago).
EPS was ₹14.82, up 16.5% YoY and up 45.3% QoQ.
NH के Q2 FY27 नतीजे (कंसोलिडेटेड आंकड़े, NSE पर दाखिल)।
राजस्व: ₹2,843.99 करोड़; पिछले साल की तुलना में 73% की बढ़त, पिछली तिमाही की तुलना में 6% की बढ़त।
शुद्ध मुनाफ़ा: ₹301.03 करोड़; पिछले साल की तुलना में 16.5% की बढ़त, पिछली तिमाही की तुलना में 45.3% की बढ़त।
ऑपरेटिंग मार्जिन: 19.5% (एक साल पहले 24.5%)।
EPS: ₹14.82; पिछले साल की तुलना में 16.5% की बढ़त, पिछली तिमाही की तुलना में 45.3% की बढ़त।
NHના Q2 FY27 પરિણામો (કન્સોલિડેટેડ આંકડા, NSE પર ફાઇલ કરેલા).
આવક (રેવન્યુ): ₹2,843.99 કરોડ; ગયા વર્ષની સરખામણીએ 73% વધારો, ગયા ક્વાર્ટરની સરખામણીએ 6% વધારો.
ચોખ્ખો નફો: ₹301.03 કરોડ; ગયા વર્ષની સરખામણીએ 16.5% વધારો, ગયા ક્વાર્ટરની સરખામણીએ 45.3% વધારો.
ઓપરેટિંગ માર્જિન: 19.5% (એક વર્ષ પહેલાં 24.5%).
EPS: ₹14.82; ગયા વર્ષની સરખામણીએ 16.5% વધારો, ગયા ક્વાર્ટરની સરખામણીએ 45.3% વધારો.
Written from the filed numbers. Not a recommendation.
Smart-money activity
17/100 · Weak over the last ~60 sessions, data 2026-10-30
- Delivery vs usual 0/30: Delivery 54.3% over the last 20 sessions vs 61.3% in the 40 before (0.89x); shares delivered per day 0.44x usual; 0 delivery-spike days (3x usual shares delivered, 40%+ delivery) in the last 20 sessions.
- Bulk/block deals 0/20: No bulk or block deals in the last 90 days.
- Insider / SAST buys 0/15: No insider buy or SAST acquisition filings in the last 90 days. Insider sells are not collected by the site, so only buy filings count.
- Mutual fund holding 11/15: 12 schemes hold it, about ₹2,231 cr in all (as of 2026-09-30). Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
- Accumulation evidence 1/15: Verdict "None", sustained score 27/100.
- Promoter pledges 5/5: No promoter pledge filings in 90 days.
A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.
Story so far
● Results ● Dividend
- 30 Oct 26Results Q2 FY27 results: profit +16.5% YoY
- 31 Jul 26Results Q1 FY27 results: profit +5.4% YoY -7.7% next session
- 17 Jul 26Dividend Dividend ₹4.5 (ex-date) -0.4% next session
- 22 May 26Results Q4 FY26 results: profit +13.5% YoY +0.5% next session
- 13 Feb 26Results Q3 FY26 results: profit −34.3% YoY -1.5% next session
- 14 Nov 25Results Q2 FY26 results: profit +30.1% YoY +13.0% next session
- 1 Aug 25Results Q1 FY26 results: profit −2.3% YoY -4.5% next session
- 1 Aug 25Dividend Dividend ₹4.5 (ex-date) -4.5% next session
- 26 May 25Results Q4 FY25 results: profit +3.4% YoY +1.1% next session
- 14 Feb 25Results Q3 FY25 results: profit +2.6% YoY -0.2% next session
- 31 Oct 24Results Q2 FY25 results: profit −12.3% YoY +2.1% next session
From official exchange filings and NSE data. How the price moved after an event describes the past, not what comes next.
Quarterly results (consolidated)
| Quarter | Revenue | Net profit | Profit YoY | Op. margin | EPS ₹ |
|---|---|---|---|---|---|
| Sept 2026 | ₹2,844 cr | ₹301 cr | +16.5% | 19.5% | 14.82 |
| Jun 2026 | ₹2,684 cr | ₹207 cr | +5.4% | 17.5% | 10.2 |
| Mar 2026 | ₹2,594 cr | ₹224 cr | +13.5% | 19.7% | 11.02 |
| Dec 2025 | ₹2,151 cr | ₹127 cr | -34.3% | 17.1% | 6.24 |
Shareholding trend
| Holder | Sept 2026 | Jun 2026 | Mar 2026 | Dec 2025 |
|---|---|---|---|---|
| Promoters | 63.27% | 63.27% | 63.27% | 63.27% |
| Foreign institutions (FII) | 9.01% | 9.40% | 9.98% | 11.10% |
| Domestic institutions (DII) | 10.68% | 9.06% | 9.15% | 7.91% |
| Mutual funds | 8.64% | 7.34% | 7.24% | 6.22% |
| Retail investors | 8.19% | 9.30% | 9.50% | 9.76% |
| Number of shareholders | 1,98,623 | 2,11,173 | 2,20,561 | 2,28,123 |
Common questions
What was Narayana Hrudayalaya Ltd.'s latest quarterly profit?
Narayana Hrudayalaya Ltd. reported a net profit of ₹301 cr for the quarter ended Sept 2026 (+16.5% on the same quarter a year earlier), on revenue of ₹2,844 cr.
How much do promoters hold in Narayana Hrudayalaya Ltd.?
Promoters held 63.27% of Narayana Hrudayalaya Ltd. at the end of Sept 2026, with 0.00% of promoter shares pledged.
Is Narayana Hrudayalaya Ltd. debt-free?
Its latest reported debt-to-equity ratio is 1.29, meaning borrowings are larger than shareholders' equity.
What is Narayana Hrudayalaya Ltd.'s P/E ratio?
About 42.8, based on the last 12 months' earnings and a price of ₹1,720.2 (data 2026-10-30).
What is the 52-week high and low of Narayana Hrudayalaya Ltd.?
The 52-week high is ₹2,093.3 and the 52-week low is ₹1,589.
Mutual funds holding Narayana Hrudayalaya Ltd.
From the monthly portfolios of the fund houses the site reads, as of 2026-09-30. 12 schemes holding about ₹2,231 cr; funds that hold it outside their top holdings may not be listed.
| Scheme | Fund house | % of fund | Value |
|---|---|---|---|
| Mirae Asset Large & Midcap Fund | Mirae Asset Mutual Fund | 1.75% | ₹750 cr |
| Mirae Asset Midcap Fund | Mirae Asset Mutual Fund | 2.13% | ₹416 cr |
| Parag Parikh Flexi Cap Fund | PPFAS Mutual Fund | 0.25% | ₹363 cr |
| Mirae Asset ELSS Tax Saver Fund | Mirae Asset Mutual Fund | 1.21% | ₹298 cr |
| NIPPON INDIA PHARMA FUND | Nippon India Mutual Fund | 1.61% | ₹148 cr |
| Mirae Asset Multicap Fund | Mirae Asset Mutual Fund | 1.63% | ₹88 cr |
| Mirae Asset Small Cap Fund | Mirae Asset Mutual Fund | 1.17% | ₹68 cr |
| Mirae Asset Flexi Cap Fund | Mirae Asset Mutual Fund | 0.95% | ₹42 cr |
| ADITYA BIRLA SUN LIFE BUSINESS CYCLE FUND | Aditya Birla Sun Life Mutual Fund | 1.86% | ₹32 cr |
| Parag Parikh ELSS Tax Saver Fund | PPFAS Mutual Fund | 0.35% | ₹19 cr |
| Mirae Asset Nifty Smallcap 250 Momentum Quality 100 ETF | Mirae Asset Mutual Fund | 0.91% | ₹9 cr |
| Mirae Asset Nifty 500 Healthcare ETF | Mirae Asset Mutual Fund | 0.92% | ₹0 cr |
Similar companies
Max Healthcare Institute Ltd (MAXHEALTH) · Aster DM Quality Care Limited (ASTERDM) · Fortis Healthcare Ltd. (FORTIS) · Global Health Limited (MEDANTA) · Krishna Institute of Medical Sciences Limited (KIMS)
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open NH in NSE Scanner →